Santes, France

Roland Beliard



 

Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 86(Granted Patents)


Location History:

  • Saintes, FR (1998)
  • Gif sur Yvette, FR (2017)
  • Santes, FR (2009 - 2018)

Company Filing History:


Years Active: 1998-2018

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Roland Beliard

Introduction

Roland Beliard is a notable inventor based in Santes, France, recognized for his significant contributions to the field of biotechnology. With a total of 14 patents to his name, Beliard has made remarkable advancements, particularly in the development of monoclonal antibodies.

Latest Patents

Among his latest patents, Beliard has developed monoclonal antibodies with enhanced ADCC function. This invention involves a method for obtaining and selecting monoclonal antibodies through an ADCC-type test. The antibodies are capable of activating type III Fcy receptors and possess a specific glycan structure. These innovative anti-D antibodies are particularly useful for preventing Rhesus isoimmunization in Rh-negative individuals, especially in cases of hemolytic disease in newborns and for conditions such as idiopathic thrombocytopenic purpura (ITP).

Career Highlights

Beliard has had a distinguished career, working with prominent organizations such as Laboratoire Français Du Fractionnement Et Des Biotechnologies and LFB Biotechnologies. His work has significantly impacted the field of biopharmaceuticals, particularly in the development of therapeutic antibodies.

Collaborations

Throughout his career, Beliard has collaborated with esteemed colleagues, including Dominique Bourel and Christophe De Romeuf. These partnerships have further enhanced his research and development efforts in biotechnology.

Conclusion

Roland Beliard's innovative work in monoclonal antibodies has made a lasting impact on medical science, particularly in the prevention and treatment of serious health conditions. His contributions continue to influence the field of biotechnology and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…